Skip to main content

Advertisement

Log in

Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial

  • Original Contribution
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract

Mentalization-based treatment in groups (MBT-G) has never been tested in adolescents with Borderline Personality Disorder (BPD) in a randomized controlled trial. The current study aimed to test the long-term effectiveness of MBT-G in an adolescent sample with BPD or BPD features (≥ 4 DSM-5 BPD criteria). Hundred and eleven patients with BPD (n = 106) or BPD features (n = 5) were randomized to either (1) a 1-year modified MBT-G program comprising three MBT introductory sessions, five individual case formulation sessions, 37 weekly MBT group sessions, and six MBT-Parent sessions, or (2) treatment as usual (TAU), defined as at least 12 individual monthly treatment sessions with follow-up assessments at 3 and 12 months post treatment. The primary outcome was the score on the Borderline Personality Features Scale for Children (BPFS-C), and secondary outcomes included clinician-rated BPD symptoms and global level of functioning as well as self-reported self-harm, depression, externalizing and internalizing symptoms, and caregiver reports. There were no statistically significant differences between MBT-G and TAU on the primary outcome measure or any of the secondary outcomes. Both groups showed improvement on the majority of clinical and social outcomes at both follow-up points, although remission rates were modest with just 35% in MBT-G and 39% in TAU 2 years after inclusion into the study. MBT-G was not superior to TAU in improving borderline features in adolescents. Although improvement was observed equally in both interventions over time, the patients continued to exhibit prominent BPD features, general psychopathology and decreased functioning in the follow-up period, which points to a need for more research and better understanding of effective components in early intervention programs. The ClinicalTrials.gov identifier is NCT02068326.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Achenbach TM (1991) Manual for the youth self-report and 1991 profile. University of Vermont Department of Psychiatry, Burlington

  2. Achenbach TM (1991) Manual for the child behavior checklist 4-18 and 1991 profile. University of Vermont Department of Psychiatry, Burlington

  3. Baldwin SA, Bauer DJ, Stice E, Rohde P (2011) Evaluating models for partially clustered designs. Psychol Methods 16(2):149–165

    PubMed  PubMed Central  Google Scholar 

  4. Bales DL, Verheul R, Hutsebaut J (2017) Barriers and facilitators to the implementation of mentalization-based treatment (MBT) for borderline personality disorder. Personal Ment Health 11(2):118–131

    PubMed  Google Scholar 

  5. Bateman A, Fonagy P (1999) Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 156:1563–1569

    CAS  PubMed  Google Scholar 

  6. Bateman A, Fonagy P (2001) Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry 158:36–42

    CAS  PubMed  Google Scholar 

  7. Bateman A, Fonagy P (2004) Mentalization-based treatment of BPD. J Personal Disord 18(1):36–51

    Google Scholar 

  8. Bateman A, Fonagy P (2008) 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry 165:631–638

    PubMed  Google Scholar 

  9. Bateman A, Fonagy P (2009) Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 166:1355–1364

    PubMed  Google Scholar 

  10. Bateman A, Fonagy P (2016) Mentalization-based treatment for personality disorders – a practical guide. Oxford University Press, Oxford

    Google Scholar 

  11. Beck JS, Beck AT, Jolly JB, Steer RA (2012) Beck youth inventories of emotional & social impairment, 2nd edn. Dansk Psykologisk Forlag, Copenhagen

    Google Scholar 

  12. Beck E, Bo S, Gondan M, Poulsen S, Pedersen L, Pedersen J, Simonsen E (2016) Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial. Trials 17(1):1–13

    Google Scholar 

  13. Beck E, Bo S, Jørgensen MS, Gondan M, Poulsen S, Storebø OJ, Andersen CF, Folmo E, Sharp C, Pedersen J, Simonsen E (2020) Mentalization-based treatment in groups for adolescents with borderline personality disorder: a randomized controlled trial. J Child Psychol Psychiatry 61(5):594–604

    PubMed  Google Scholar 

  14. Becker DF, Grilo CM, Edell WS, Mcglashan TH (2002) Diagnostic efficiency of borderline personality disorder criteria in hospitalized adolescents: comparison with hospitalized adults. Am J Psychiatry 159(12):2042–2047

    PubMed  Google Scholar 

  15. Chanen AM, Jackson HJ, Mcgorry PD, Allot KA, Clarkson V, Yuen HP (2004) Two-year stability of personality disorder in older adolescent outpatients. J Personal Disord 18(6):526–541

    Google Scholar 

  16. Chanen AM, Jackson HJ, McCutcheon LK, Jovev M, Dudgeon P, Yuen HP, McGorry PD (2008) Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. Br J Psychiatry 193(6):477–484

    PubMed  Google Scholar 

  17. Chanen AM, McCutcheon LK (2013) Prevention and early intervention for borderline personality disorder: current status and recent evidence. Br J Psychiatry 202:24–29

    Google Scholar 

  18. Chanen AM (2015) Borderline personality disorder in young people: are we there yet? J Clin Psychol 71(8):778–791

    PubMed  Google Scholar 

  19. Chanen AM, Berk M, Thompson K (2016) Integrating early intervention for borderline and mood disorders. Harv Rev Psychiatry 24(5):330–341

    PubMed  Google Scholar 

  20. Chanen AM, Sharp C, Hoffman P (2017) The global alliance for prevention and early intervention for borderline personality disorder. Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry 16:215–216

    PubMed  PubMed Central  Google Scholar 

  21. Committee for Medicinal Products for Human Use (CMPH) (2015) Guideline on adjustment for baseline covariates in clinical trials. European Medicines Agency, London

    Google Scholar 

  22. Crick NR, Close DM, Woods K (2005) Borderline personality features in childhood: a short-term longitudinal study. Dev Psychopathol 17:1051–1070

    PubMed  Google Scholar 

  23. Flight L, Allison A, Dimairo M, Lee E, Mandefield L, Walters SJ (2016) Recommendations for the analysis of individually randomised controlled trials with clustering in one arm–a case of continuous outcomes. BMC Med Res Methodol 16:1–13

    Google Scholar 

  24. Folmo EJ, Karterud SW, Bremer K, Walther KL, Kvarstein EH, Pedersen GAF (2017) The design of the MBT-G adherence and quality scale. Scand J Psychol 58:341–349

    PubMed  Google Scholar 

  25. Gunderson J et al (2011) Ten-year course of borderline personality disorder: psychopathology and function from the collaborative longitudinal personality disorders study. Arch Gen Psychiatry 68(8):827–837

    PubMed  PubMed Central  Google Scholar 

  26. Ha C, Balderas JC, Zanarini MC, Oldham J, Sharp C (2014) Psychiatric comorbidity in hospitalized adolescents with borderline personality disorder. J Clin Psychiatry 75(5):e457–e464

    PubMed  Google Scholar 

  27. Hayes AF (2009) Beyond Baron and Kenny: statistical mediation analysis in the new millennium. Commun Monogr 76(4):408–420

    Google Scholar 

  28. Hutsebaut J, Videler AC, Verheul R, Van Alphen SPJ (2019) Managing borderline personality disorder from a life course perspective: clinical staging and health management. Personal Disord Theory Res Treat 19(4):309–316

    Google Scholar 

  29. Jørgensen CR, Freund C, Boye R, Jordet H, Andersen D, Kjølbye M (2013) Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand 127:305–317

    PubMed  Google Scholar 

  30. Jørgensen CR, Bøye R, Andersen D, Døssing Blaabjerg AH, Freund C, Jordet H, Kjølbye M (2014) Eighteen months post-treatment naturalistic follow-up study of mentalization-based therapy and supportive group treatment of borderline personality disorder: clinical outcomes and functioning. Nord Psychol 66(4):254–273

    Google Scholar 

  31. Karterud SW, Bateman AW (2011) Manual for mentaliseringsbasert psykoedukativ gruppeterapi (MBT-I). Gyldendal akademisk, Oslo

    Google Scholar 

  32. Karterud SW (2012) Manual for mentaliseringsbasert gruppeterapi (MBT-G). Gyldendal akademisk, Oslo

    Google Scholar 

  33. Karterud SW (2013) Personlighedsforstyrrelser i DSM-IV og ICD-10. In: Karterud SW, Wilberg T, Urnes O (eds) Personlighedspsykiatri, 1st edn. Akademisk Forlag, København, pp 209–281

    Google Scholar 

  34. Kvarstein EH, Pedersen G, Folmo E, Urnes Ø, Johansen MS, Hummelen B, Karterud S (2019) Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder–the impact of clinical severity. Psychol Psychother Theory Res Pract 92:91–111

    Google Scholar 

  35. Laurenssen E, Luyten P, Kikkert MJ, Westra D, Peen J, Soons MBJ et al (2018) Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial. Psychol Med 48(15):2522–2529

    PubMed  Google Scholar 

  36. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F (2011) Borderline personality disorder. Lancet 377(9759):74–84

    PubMed  Google Scholar 

  37. Linehan MM, Korslund KE, Harned MS et al (2015) Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry 72(5):475–482

    PubMed  Google Scholar 

  38. McCauley E, Berk MS, Asarnow JR, Adrian M, Cohen J, Korslund K (2018) Efficacy of dialectical behavior therapy for adolescents at high risk for suicide a randomized clinical trial. JAMA Psychiatry 75(8):777–785

    PubMed  PubMed Central  Google Scholar 

  39. Mehlum L, Tormoen AJ, Ramberg M, Haga E, Diep LM, Laberg S, Groholt B (2014) Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. J Am Acad Child Adolesc Psychiatry 53(10):1082–1091

    PubMed  Google Scholar 

  40. Mehlum L, Ramberg M, Tormoen AJ, Haga E, Diep LM, Stanley BH, Groholt B (2016) Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. J Am Acad Child Adolesc Psychiatry 55(4):295–300

    PubMed  Google Scholar 

  41. Mehlum L, Ramleth R, Tørmoen AJ, Haga E, Diep LM, Stanley BH, Grøholt B (2019) Long term effectiveness of dialectical behavior therapy versus enhanced usual care for adolescents with self-harming and suicidal behavior. J Child Psychol Psychiatry 60(10):1112–1122

    PubMed  Google Scholar 

  42. Newton-Howes G, Clark LA, Chanen A (2015) Personality disorder across the life course. Lancet 385(9969):727–734

    PubMed  Google Scholar 

  43. Robinson P, Hellier J, Barett B, Barzdaitiene D, Bateman A, Bogaardt A et al (2016) The NOURISHED randomised controlled trial comparing mentalisation-based treatment for eating disorders (MBT-ED) with specialist supportive clinical management (SSCM-ED) for patients with eating disorders and symptoms of borderline personality disorder. Trials 17:549

    PubMed  PubMed Central  Google Scholar 

  44. Rossouw TI, Fonagy P (2012) Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 51:1304–1313

    PubMed  Google Scholar 

  45. Rubin DB (1987) Multiple imputation for non-response in surveys. John Wiley & Sons, New York

    Google Scholar 

  46. Santisteban DA, Mena MP, Muir J, McCabe BE, Abalo C, Cummings AM (2015) The efficacy of two adolescent substance abuse treatments and the impact of comorbid depression: results of a small randomized controlled trial. Psychiatr Rehabil J 38(1):55–64

    PubMed  PubMed Central  Google Scholar 

  47. Schuppert HM, Timmerman ME, Bloo J, van Gemert TG, Wiersema HM, Minderaa RB, Nauta MH (2012) Emotion regulation training for adolescents with borderline personality disorder traits: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 51(12):1314–1323.e2

    PubMed  Google Scholar 

  48. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H et al (1983) A children’s global assessment scale. Arch Gen Psychiatry 40(11):1228–1231

    CAS  Google Scholar 

  49. Sharp C, Mosko O, Chang B, Ha C (2011) The cross-informant concordance and concurrent validity of the borderline personality features scale for children in a community sample of boys. Clin Child Psychol Psychiatry 16(3):335–349

    PubMed  Google Scholar 

  50. Sharp C, Green KL, Yaroslavsky I, Venta A, Zanarini MC, Pettit J (2012) The incremental validity of borderline personality disorder relative to major depressive disorder for suicidal ideation and deliberate self-harm in adolescents. J Personal Disord 26(6):927–938

    Google Scholar 

  51. Stepp SD, Pilkonis PA, Hipwell AE, Loeber R, Stouthamer-Loeber M (2010) Stability of borderline personality disorder features in girls. J Pers Disord 24(4):460–472

    PubMed  PubMed Central  Google Scholar 

  52. Thastum M, Ravn K, Sommer S, Trillingsgaard A (2009) Reliability, validity and normative data for the Danish beck youth inventories: development and aging. Scand J Psychol 50:47–54

    PubMed  Google Scholar 

  53. Thompson KN, Jackson H, Cavelti M, Betts J, Mccutcheon L, Jovev M, Chanen AM (2019) The clinical significance of subthreshold borderline personality disorder features in outpatient youth. J Personal Disord 33(1):71–81

    Google Scholar 

  54. Vrouva I, Fonagy P, Fearon PRM, Rossouw TI (2010) The risk-taking and self-harm inventory for adolescents: development and psychometric evaluation. Psychol Assess 22:852–865

    PubMed  Google Scholar 

  55. Winograd G, Cohen P, Chen H (2008) Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. J Child Psychol Psychiatry 49:933–941

    PubMed  Google Scholar 

  56. Zanarini MC, Frankenburg FR (2001) Zanarini rating scale for borderline personality disorder (ZAN-BPD). Harvard Medical School, Belmont

    Google Scholar 

  57. Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J (2003) Zanarini rating scale for borderline personality disorder (Zan-BPD): a continuous measure of DSM-IV borderline psychopathology. J Personal Disord 17(3):233–242

    Google Scholar 

  58. Zanarini MC et al (2005) The McLean study of adult development (MSAD): overview and implications of the first six years of prospective follow-up. J Personal Disord 19(5):505–523

    Google Scholar 

  59. Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB (2007) The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry 164(6):929–935

    PubMed  Google Scholar 

  60. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G (2012) Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis ii comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry 169(5):476–483

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank all the participants and their families for participating in this study. We thank the staff at the child and adolescent psychiatry in Region Zealand, and their managers for their support. We are grateful to the therapists and supervisors. We thank the members of the steering committee and a special acknowledgement of Michael Maagensen for assisting in the development of the medical protocol. Thank you to our research assistants Louise Lejbach and Christian Fjellerad Andersen, and also to Karterud for his supervision of therapists and advice on the design of the MBT group program. Thank you to Trygfonden, Department of Child and Adolescent Psychiatry, Psychiatric Research Unit and the Health Scientific Research Fund of Region Zealand, and Department of Health and Medical Sciences at University of Copenhagen for funding this study.

Funding

TrygFonden (Grant Number 115638), Department of Child and Adolescent Psychiatry Region Zealand, Psychiatric Research Unit Region Zealand, the Health Scientific Research Fund of Region Zealand, and Department of Health and Medical Sciences, University of Copenhagen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mie Sedoc Jørgensen.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The trial is also approved by the Regional Ethics Committee of Zealand (No: SJ-371), and is registered at the Danish Data Protection Agency (No: REG-55-2014).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jørgensen, M.S., Storebø, O.J., Bo, S. et al. Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial. Eur Child Adolesc Psychiatry 30, 699–710 (2021). https://doi.org/10.1007/s00787-020-01551-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-020-01551-2

Keywords

Navigation